The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Gruzdeva O.V.

Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russia;
Kemerovo State Medical Academy, Kemerovo, Russia

Palicheva E.I.

Research institute for complex issues of cardiovascular diseases, Kemerovo, Russia;
Kemerovo state medical university, Kemerovo, Russia

Maksimov S.A.

Federal State Budgetary Scientific Institution «Research Institute for Complex Issues of Cardiovascular Diseases», Kemerovo, Russia, 650002

Zhilyaeva T.P.

Federal State Budgetary Scientific Institution Research Institute for Complex Issues of Cardiovascular Diseases, 650002, Kemerovo, Russian Federation

Dyleva Yu.A.

Federal State Budgetary Institution Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russian Federation

Makarov S.A.

Kafedra fakul'tetskoĭ khirurgii SPb GMU im. akad. I.P. Pavlova MZSR RF;
Gorodskoĭ Tsentr sovremennykh khirurgicheskikh tekhnologiĭ 31-ĭ klinicheskoĭ bol'nitsy, Sankt-Peterburg

Gender and age characteristics of glucose concentration in the blood and total cholesterol, a risk factor for cardiovascular diseases of results dispensary observation

Authors:

Gruzdeva O.V., Palicheva E.I., Maksimov S.A., Zhilyaeva T.P., Dyleva Yu.A., Makarov S.A.

More about the authors

Journal: Laboratory Service. 2016;5(2): 15‑21

Read: 6123 times


To cite this article:

Gruzdeva OV, Palicheva EI, Maksimov SA, Zhilyaeva TP, Dyleva YuA, Makarov SA. Gender and age characteristics of glucose concentration in the blood and total cholesterol, a risk factor for cardiovascular diseases of results dispensary observation. Laboratory Service. 2016;5(2):15‑21. (In Russ.)
https://doi.org/10.17116/labs20165215-21

Recommended articles:

References:

  1. Order of the Russian Ministry of Health №928n from 15 November 2012, «On approval of the provision of medical care to patients with acute ischemic stroke». Link active on 25.01.2016. Available at: http://www.ros-med.info/orders/index.php?id=59&action=order (In Russ.)
  2. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, Fang MC, Fisher M, Furie KL, Heck DV, Johnston SC, Kasner SE, Kittner SJ, Mitchell PH, Rich MW, Richardson D, Schwamm LH, Wilson JA; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(7):2160-2236. doi:10.1161/STR.0000000000000024
  3. Ringleb PA, G Bousser, Ford G, P Bath, Brainin M, Caso V, Cervera Á, Chamorro A, Charlotte Cordonnier, Csiba L, Davalos A, Diener H, Ferro J, W Hacke, Hennerici M, Kaste M, Langhorne P, Lees K, Leys D, Lodder J, Markus HS, Mas J L, Mattle HP, Muir K, Norrving B, Obach V, Paolucci S, Ringelstein EB, Schellinger PD, Sivenius J, Skvortsova V, Stibrant K, Sunnerhagen, Thomassen L, Toni D, Rr von Kummer, Gunnar Wahlgren, Walker MF, Wardlaw J. Ischaemic stroke and transient ischaemic attack. European Handbook of Neurological Management. Vol. 1, 2nd ed. Edited by Gilhus NE, Barnes MP, Brainin M. Blackwell Publishing Ltd.; 2011:113. ISBN: 978-1-405-18533-2.
  4. EFNS 2011 Ischaemic Stroke and Transient Ischaemic Attack. Link active on 25.01.2016. Available at: http://onlinelibrary.wiley.com/doi/10.1002/9781444328394.ch9/summary
  5. Li C, Engström G, Berglund G, Janzon L, Hedblad B. Incidence of ischemic stroke in relation to asymptomatic carotid artery atherosclerosis in subjects with normal blood pressure. A prospective cohort study. Cerebrovasc Dis. 2008;26(3):297.  doi:10.1159/000149577
  6. Gorelick PB. Lipoprotein-associated phospholipase A2 and risk of stroke. AM J Cardiol. 2008;101(12A):34-40.  doi:10.1016/j.amjcard.2008.04.017
  7. Russian Society of Angiology and Vascular Surgery, the Association of Cardiovascular Surgeons of Russia, Russian Society of endovascular surgeons and interventional radiologists, Russian Scientific Society of Cardiology, Phlebology Association of Russia. National guidelines for management of patients with diseases of brachiocephalic arteries. Moscow; 2013. Link active on 01.25.2016. Available at: http://xn----9sbdbejx7bdduahou3a5d.xn--p1ai/upload/brachiocephalic_artery.pdf (In Russ.)
  8. Rajamani K, Chaturvedi S. Stroke prevention-surgical and interventional approaches to carotid stenosis. Neurotherapeutics. 2011;8(3):503-514.  doi:10.1007/s13311-011-0052-2
  9. Moussa ID, Rundek T, Mohr JP. Asymptomatic Carotid Artery Stenosis: A Primer on Risk Stratification and Management. Informa UK Ltd.; 2007:141-148.
  10. Balestrini S, Lupidi F, Balucani C, Altamura C, Vernieri F, Provinciali L, Silvestrini M. One-year progression of moderate asymptomatic carotid stenosis predicts the risk of vascular events. Stroke. 2013;44(3):792-794.  doi:10.1161/STROKEAHA.112.671461
  11. Musialek P, Tracz W, Tekieli L, Pieniazek P, Kablak-Ziembicka A, Przewlocki T, Stepien E, Kapusta P, Motyl R, Stepniewski J, Undas A, Podolec P. Multimarker approach in discriminating patients with symptomatic and asymptomatic atherosclerotic carotid artery stenosis. J Clin Neurol. 2013;9(3):165-175.  doi:10.3988/jcn.2013.9.3.165
  12. Nozadze D, Semenova A, Kaminnaya V, Vlasik T, Sergienko I. Lipoprotein-associated phospholipase A2 — a new position in the risk stratification? Ateroskleroz i dislipidemii. 2011;1:41-47. (In Russ.)
  13. Soloveva L, Shmonin A, Emanuel Yu, Stolyarov M, Bondareva E, Mazing A, Lazareva N, Kholopova I, Blinova T, Kharitonova T, Lapin S, Emanuel V, Melnikova E. Clinical and Laboratory biomarkers in patients with Atherothrombotic Stroke. Klinicheskaya laboratornaya diagnostika. 2015;10(10-15):12-16. (In Russ.)
  14. Zhang F, Li X, Dong Q, Wang Y, Zhang H. Risk of acute cerebral infarction and plasma asymmetrical dimethylarginine and homocysteine levels: a clinical correlation analysis of Chinese population. J Stroke Cerebrovasc Dis. 2014;23(9):2225-2232. doi:10.1016/j.jstrokecerebrovasdis.2014.04.001
  15. Zhou Y, Han W, Gong D, Man C, Fan Y. Hs-CRP in stroke: A meta-analysis. Clin Chim Acta. 2016;453:21-27.  doi:10.1016/j.cca.2015.11.027
  16. Nave AH, Lange KS, Leonards CO, Siegerink B, Doehner W, Landmesser U, Steinhagen-Thiessen E, Endres M, Ebinger M. Lipoprotein (a) as a risk factor for ischemic stroke: a meta-analysis. Atherosclerosis. 2015;242(2):496-503.  doi:10.1016/j.atherosclerosis.2015.08.021
  17. Van Lammeren GW, Moll FL, De Borst GJ, De Kleijn DPV, De Vries JPM, Pasterkamp G. Atherosclerotic plaque biomarkers: beyond the horizon of the vulnerable plaque. Current Cardiology Reviews. 2011;7(1):22-27.  doi:10.2174/157340311795677680
  18. Elkind MSV, Tai W, Coates K, Paik MC, Sacco RL. High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke. Arch Intern Med. 2006;166(19):2073-2079. doi:10.1001/archinte.166.19.2073
  19. Oei HS, Van der Meer IV, Hofman A, Koudstaal PJ, Stijnen T, Breteler MMB, Witteman JCM. Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: The Rotterdam Study. Circulation. 2005;111(5):570-575.  doi:10.1161/01.CIR.0000154553.12214
  20. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347(20):1557-1565. doi:10.1056/NEJMoa021993
  21. Di Napoli M, Schwaninger M, Cappelli R, Ceccarelli E, Di Gianfilippo G, Donati C et al. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP pooling project members. Stroke. 2005;36(6):1316-1329. doi:10.1161/01.STR.0000165929.78756.ed
  22. Smolders B, Lemmens R, Thijs V. Lipoprotein (a) and stroke a meta-analysis of observational studies. Stroke. 2007;38(6):1959-1966. doi:10.1161/STROKEAHA.106.480657
  23. Christogiannis L, Milionis HJ, Elisaf M. Lipoprotein (a) and stroke: an overview. J Stroke Cerebrovasc Dis. 2010;19(6):498.
  24. Fialová L, Pilecková N, Bauer J, Soukupová J, Kalousová M, Malbohan I et al. Pregnancy-associated plasma protein-A in patients with cerebrovascular diseases-a pilot study. Prague Med Rep. 2006;107(1):37-45.
  25. Chen S, Li N, Deb-Chatterji M, Dong Q, Kielstein JT, Weissenborn K et al. Asymmetric dimethylarginine as marker and mediator in ischemic stroke. Review. Int J Mol Sci. 2012;13(12):15983-16004. doi:10.3390/ijms131215983
  26. Cucchiara BL, Messe SR, Sansing L, MacKenzie L, Taylor RA, Pacelli J et al. Lipoprotein-associated phospholipase A2 and C-reactive protein for risk-stratification of patients with TIA. Stroke. 2009;40(7):2332-2336. doi:10.1161/STROKEAHA.109.553545
  27. England TJ, Abaei M, Auer DP, Lowe J, Jones DR, Sare G, Walker M, Bath PM. Granulocyte-colony stimulating factor for mobilizing bone marrow stem cells in subacute stroke: the stem cell trial of recovery enhancement after stroke 2 randomized controlled trial. Stroke. 2012;43(2):405-411.  doi:10.1161/STROKEAHA.111.636449
  28. Johnsen SP, Hundborg HH, Sørensen HT, Orskov H, Tjønneland A, Overvad K, Jørgensen JO. Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke. J Clin Endocrinol Metab. 2005;90(11):5937-5941.
  29. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35-41.  doi:10.1161/01.STR.24.1.35

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.